AACR: OncoMyx’s engineered rabbit pox virus shows promise in lung cancer model
Angus Liu | Apr 12, 2021 7:55am Last year, OncoMyx Therapeutics unveiled preclinical data showing its engineered rabbit pox virus therapy could slow tumor growth in mouse models of melanoma and bone cancer. Now, it’s unveiling more preclinical evidence, this time in non-small cell lung cancer (NSCLC). To make its therapy,… Read More